Nov 2, 2022, 10:10 AM by

BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.

Nov 2, 2022, 10:10 AM by

BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.

Nov 2, 2022, 10:09 AM by

Nov 2, 2022, 09:59 AM by

Nov 2, 2022, 09:58 AM by

Nov 2, 2022, 09:54 AM by

Nov 2, 2022, 01:00 AM by User Not Found

Bio-IT World | Best practice surveillance protocols for seven diseases caused by group A Streptococcus (strep A) were recently released, and public health researchers are now actively working to identify several key sentinel sites to implement them. Harmonizing case definitions and the surveillance methodologies is a key step in accelerating development of a safe, effective, and affordable strep A vaccine to prevent these diseases.

Nov 1, 2022, 10:38 AM by

BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that it has received agreement from the US Food and Drug Administration (FDA) on the Phase 3 clinical trial design for its lead candidate for Dry Eye Disease (DED), BRM421, at the End of Phase 2 Meeting. BRIM will submit the Phase 3 study protocol to the FDA in Q4 2022.

Nov 1, 2022, 10:37 AM by

Findings illustrate promise of technology to lower misdiagnosis rate for deadliest form of skin cancer

Nov 1, 2022, 10:28 AM by

Nov 1, 2022, 10:27 AM by

Nov 1, 2022, 10:26 AM by

Nov 1, 2022, 10:06 AM by

Nov 1, 2022, 10:06 AM by

Nov 1, 2022, 10:05 AM by

Nov 1, 2022, 10:05 AM by

Nov 1, 2022, 10:04 AM by

Nov 1, 2022, 01:00 AM by User Not Found

Bio-IT World | It’s been a big month for sequencing news. Last week, Oxford Nanopore announced the PromethION 2 (“P2”) Solo sequencer and a new collaboration with 10X Genomics to enable a streamlined workflow for sequencing full-length transcripts in single reads.

Oct 31, 2022, 17:33 PM by

Drug safety and pharmacovigilance (DSPV) teams that license access to the PubHive Navigator platform can now access the newest MedDRA version when performing signal evaluation and reporting activities

Oct 31, 2022, 17:33 PM by

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.